SG
EW icon

StoneX Group’s Edwards Lifesciences EW Stock Holding History

StoneX Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,005
Closed -$647K – 715
2024
Q2 		$647K Buy
7,005
+122
+2% +$10.8K 0.05% 280
2024
Q1 		$658K Buy
6,883
+1,149
+20% +$96.5K 0.06% 266
2023
Q4 		$437K Buy
5,734
+2,009
+54% +$140K 0.04% 325
2023
Q3 		$258K Buy
3,725
+916
+33% +$73.6K 0.03% 449
2023
Q2 		$265K Buy
2,809
+120
+4% +$10.4K 0.03% 444
2023
Q1 		$222K Buy
+2,689
New +$211K 0.02% 500
2022
Q3 		– Sell
-2,719
Closed -$259K – 603
2022
Q2 		$259K Sell
2,719
-810
-23% -$83.9K 0.03% 456
2022
Q1 		$415K Buy
+3,529
New +$396K 0.03% 397

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

StoneX Group's EW Position: Q3 2024 in Review

StoneX Group sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 7,005 shares — an estimated $647K sold.

StoneX Group first reported a position in EW in Q1 2022 and held it in 8 quarters. The position peaked at $658K in Q1 2024. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • StoneX Group reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • StoneX Group sold 7,005 Edwards Lifesciences shares in Q3 2024, an estimated $647K.
  • StoneX Group first reported a position in Edwards Lifesciences in Q1 2022 and held it in 8 quarters.
  • StoneX Group's Edwards Lifesciences position peaked at $658K in Q1 2024.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on StoneX Group's 13F filing for Q3 2024, filed 12 Nov 2024.